Banque Cantonale Vaudoise’s AstraZeneca AZN Stock Holding History

Banque Cantonale Vaudoise’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-383	Closed	-$70K	–	874
2025 Q4	$70K	Buy	383 +7	+2%	+$1.23K	﹤0.01%	665
2025 Q3	$58K	Sell	376 -46	-11%	-$6.96K	﹤0.01%	669
2025 Q2	$59K	Hold	422	–	–	﹤0.01%	633
2025 Q1	$62K	Buy	+422	New	+$61.1K	﹤0.01%	667
2024 Q3	$69K	Sell	442 -693	-61%	-$112K	﹤0.01%	593
2024 Q2	$177K	Buy	1,135 +500	+79%	+$75.2K	0.01%	616
2024 Q1	$86K	Hold	635	–	–	﹤0.01%	694
2023 Q4	$86K	Sell	635 -139	-18%	-$18.1K	﹤0.01%	712
2023 Q3	$105K	Hold	774	–	–	0.01%	820
2023 Q2	$111K	Hold	774	–	–	0.01%	839
2023 Q1	$107K	Hold	774	–	–	0.01%	845
2022 Q4	$105K	Hold	774	–	–	0.01%	848
2022 Q3	$85K	Hold	774	–	–	﹤0.01%	906
2022 Q2	$102K	Hold	774	–	–	0.01%	889
2022 Q1	$102K	Hold	774	–	–	﹤0.01%	921
2021 Q4	$90K	Hold	774	–	–	﹤0.01%	975
2021 Q3	$93K	Buy	774 +139	+22%	+$16.2K	﹤0.01%	950
2021 Q2	$76K	Sell	635 -1,943	-75%	-$213K	﹤0.01%	1001
2021 Q1	$256K	Buy	2,578 +1,943	+306%	+$195K	0.01%	717
2020 Q4	$63K	Hold	635	–	–	﹤0.01%	913
2020 Q3	$70K	Buy	+635	New	+$70.6K	﹤0.01%	877

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Banque Cantonale Vaudoise's AZN Position: Q1 2026 in Review

Banque Cantonale Vaudoise sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 383 shares — an estimated $70K sold.

Banque Cantonale Vaudoise first reported a position in AZN in Q3 2020 and held it in 21 quarters. The position peaked at $256K in Q1 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Banque Cantonale Vaudoise reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Banque Cantonale Vaudoise sold 383 AstraZeneca shares in Q1 2026, an estimated $70K.
Banque Cantonale Vaudoise first reported a position in AstraZeneca in Q3 2020 and held it in 21 quarters.
Banque Cantonale Vaudoise's AstraZeneca position peaked at $256K in Q1 2021.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.